科研之友
微信
新浪微博
Facebook
分享链接
摘要
Heparin-induced thrombocytopenia is a common and clinically important drug-induced complication that can cause life- and limb-threatening thrombosis. Epidemiologically, the disease has been studied in many different clinical settings, but little is known about it in cancer patients, a population at increased risk for thrombosis and thus exposure to heparin products. Additionally, thrombocytopenia is a common finding in cancer patients. The convergence of these variables highlights the importance of an increased understanding of the disease in cancer patients. (JNCCN 2011;9:781-787)
- 出版日期2011-7
